Hidetoshi Takedatsu Selected Research

Hidetoshi Takedatsu Research Topics

Disease

11	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2021 - 01/2002
11	Colitis 01/2020 - 01/2002
10	Ulcerative Colitis 01/2022 - 01/2002
9	Inflammation (Inflammations) 04/2021 - 01/2002
7	Crohn Disease (Crohn's Disease) 01/2021 - 01/2002
4	Neoplasms (Cancer) 06/2018 - 02/2004
3	Fibrosis (Cirrhosis) 04/2021 - 03/2018
2	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2022 - 03/2018
2	Intestinal Diseases (Diseases, Intestinal) 03/2018 - 04/2014
2	Stomach Neoplasms (Stomach Cancer) 01/2015 - 01/2015
1	Disease Progression 01/2022
1	Ulcer 09/2021
1	Wounds and Injuries (Trauma) 09/2021
1	Alcoholic Fatty Liver 04/2021
1	COVID-19 11/2020
1	Pathologic Constriction (Stenosis) 06/2020
1	Hemorrhage 05/2019
1	Polyps 05/2019
1	Liver Cirrhosis (Hepatic Cirrhosis) 05/2016
1	Sepsis (Septicemia) 05/2016
1	Ascites 05/2016
1	Thrombosis (Thrombus) 05/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Abdominal Pain (Pain, Abdominal) 10/2015
1	Gastrointestinal Hemorrhage (Hematochezia) 10/2015
1	Adenocarcinoma of Lung 10/2015
1	Varicose Veins (Varicose Vein) 05/2012
1	Autoimmune Pancreatitis 02/2012
1	Immunoglobulin G4-Related Disease 02/2012

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 09/2021 - 06/2004
4	AntibodiesIBA 01/2020 - 06/2004
4	Dextran SulfateIBA 09/2017 - 01/2009
3	Peptides (Polypeptides)IBA 09/2021 - 02/2004
3	EnzymesIBA 03/2018 - 04/2014
2	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022 - 03/2018
2	Myeloblastin (Proteinase 3)IBA 01/2022 - 03/2018
2	AcidsIBA 09/2021 - 09/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2020 - 01/2020
2	Dextrans (Dextran)FDA Link 01/2020 - 08/2008
2	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2020 - 08/2008
2	SteroidsIBA 03/2018 - 06/2014
2	ImmunosorbentsIBA 01/2018 - 04/2014
2	Pharmaceutical PreparationsIBA 09/2017 - 10/2015
2	Therapeutic UsesIBA 04/2013 - 03/2010
2	Immunoglobulin G (IgG)IBA 02/2012 - 03/2007
1	CollagenIBA 09/2021
1	RADA16-IIBA 09/2021
1	HydrogelsIBA 09/2021
1	Ethanol (Ethyl Alcohol)IBA 09/2021
1	SolutionsIBA 09/2021
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 04/2021
1	Bile Acids and Salts (Bile Acids)IBA 04/2021
1	elobixibatIBA 04/2021
1	bile acid binding proteinsIBA 04/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Leucine (L-Leucine)FDA Link 01/2021
1	Angiotensin-Converting Enzyme 2IBA 11/2020
1	Transient Receptor Potential ChannelsIBA 08/2020
1	Immunologic Factors (Immunomodulators)IBA 06/2020
1	GlucansIBA 01/2020
1	AnkyrinsIBA 09/2018
1	TRPA1 Cation ChannelIBA 09/2018
1	theasinensin AIBA 06/2018
1	Sulfonic AcidsIBA 03/2018
1	pirfenidoneIBA 03/2018
1	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2018
1	IronIBA 09/2017
1	Coloring Agents (Dyes)IBA 09/2017
1	Drinking WaterIBA 09/2017
1	AdrenomedullinIBA 09/2016
1	Tolvaptan FDA Link 05/2016
1	DiureticsIBA 05/2016
1	Antisense OligonucleotidesIBA 10/2015
1	Pemetrexed (MTA)FDA Link 10/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2015
1	Monoclonal AntibodiesIBA 10/2015
1	Carboplatin (JM8)FDA LinkGeneric 10/2015
1	Bevacizumab (Avastin)FDA Link 10/2015
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2015
1	Sizofiran (Schizophyllan)IBA 06/2012
1	Macrophage Migration-Inhibitory FactorsIBA 06/2012
1	EnbucrilateIBA 05/2012
1	Immunoglobulins (Immunoglobulin)IBA 02/2012
1	PrebioticsIBA 08/2011
1	HMGB1 Protein (HMG1)IBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 09/2008
1	Facilitative Glucose Transport Proteins (Glucose Transporter)IBA 09/2008
1	Piroxicam (Feldene)FDA LinkGeneric 09/2008

Therapy/Procedure

7	Therapeutics 06/2020 - 04/2013
2	Blood Component Removal (Apheresis) 02/2016 - 03/2010
2	Immunotherapy 06/2004 - 02/2004
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 05/2016
1	Peritoneovenous Shunt 05/2016
1	Activities of Daily Living (ADL) 05/2016
1	Colectomy 10/2015
1	Drug Therapy (Chemotherapy) 10/2015
1	Esophagectomy 01/2015
1	Extracorporeal Circulation 03/2010